000 01287 a2200361 4500
005 20250511161244.0
264 0 _c19761121
008 197611s 0 0 eng d
022 _a0021-9150
024 7 _a10.1016/0021-9150(76)90148-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRogers, M P
245 0 0 _aEffects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.
_h[electronic resource]
260 _bAtherosclerosis
_cSep 1976
300 _a565-73 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBlood Proteins
_xphysiology
650 0 4 _aClofibrate
_xtherapeutic use
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHeparin
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLipoprotein Lipase
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTime Factors
650 0 4 _aTriglycerides
_xblood
700 1 _aBarnett, D
700 1 _aRobinson, D S
773 0 _tAtherosclerosis
_gvol. 24
_gno. 3
_gp. 565-73
856 4 0 _uhttps://doi.org/10.1016/0021-9150(76)90148-9
_zAvailable from publisher's website
999 _c978882
_d978882